Sherry Beckman

Associate Director, Drug Safety and Pharmacovigilance at Biosplice Therapeutics - San Diego, CA, us

Sherry Beckman's Contact Details
HQ
N/A
Location
California,United States
Company
Biosplice Therapeutics
Sherry Beckman's Company Details
Biosplice Therapeutics logo, Biosplice Therapeutics contact details

Biosplice Therapeutics

San Diego, CA, us • 100 - 249 Employees
BioTech/Drugs

Biosplice is developing first-in-class, small-molecule therapeutics based on pioneering science of alternative pre-mRNA splicing. Stemming from foundational discoveries in Wnt pathway modulation, Biosplice has elucidated novel biology linking CLK/DYRK kinases to the therapeutic regulation of alternative splicing. Alternative splicing is an essential biological mechanism that regulates the diversification of proteins in a cell, which, in turn, determines cell type and function. Biosplice's target class governs the selection of tissue-specific mRNA splice sites, making them attractive, druggable targets within the cellular "command and control" center.Biosplice's drugs in clinical development include lorecivivint for osteoarthritis (in Phase 3), cirtuvivint for numerous cancers, and a broad pipeline that ranges from Alzheimer's disease to other degenerative conditions. Learn more at https://www.biosplice.com

Biotechnology
Details about Biosplice Therapeutics
Frequently Asked Questions about Sherry Beckman
Sherry Beckman currently works for Biosplice Therapeutics.
Sherry Beckman's role at Biosplice Therapeutics is Associate Director, Drug Safety and Pharmacovigilance.
Sherry Beckman's email address is ***@biosplice.com. To view Sherry Beckman's full email address, please signup to ConnectPlex.
Sherry Beckman works in the Research industry.
Sherry Beckman's colleagues at Biosplice Therapeutics are Melissa Triebell, Christopher Swearingen, Emily Creger, Heli Ghandehari, Melinda Pedraza, Paula Sepeda, Labed Dabbagh and others.
Sherry Beckman's phone number is N/A
See more information about Sherry Beckman